{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T04:56:17Z","timestamp":1776574577599,"version":"3.51.2"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10286-019-00637-5","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T16:06:02Z","timestamp":1568822762000},"page":"173-175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Neurogenic orthostatic hypotension induced by tizanidine"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4728-0233","authenticated-orcid":false,"given":"Maureen C.","family":"Farrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Italo","family":"Biaggioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4518-6801","authenticated-orcid":false,"given":"Cyndya A.","family":"Shibao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"637_CR1","unstructured":"Acorda Therapeutics Inc. (2013) Zanaflex (Tizanidine) [package insert]. Acorda Therapeutics Inc. Ardsley"},{"key":"637_CR2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/cpt.1233","volume":"105","author":"S Chaugai","year":"2019","unstructured":"Chaugai S, Dickson AL, Shuey MM et al (2019) Co-prescription of strong CYP1A2 inhibitors and the risk of tizanidine-associated hypotension: a retrospective cohort study. Clin Pharmacol Ther 105:703\u2013709. \nhttps:\/\/doi.org\/10.1002\/cpt.1233","journal-title":"Clin Pharmacol Ther"},{"key":"637_CR3","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-5","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5, 5th edn. American Psychiatric Association, Washington DC","edition":"5"},{"key":"637_CR4","volume-title":"Primer on the autonomic nervous system","author":"JM Luther","year":"2012","unstructured":"Luther JM (2012) Primer on the autonomic nervous system, 3rd edn. Elsevier, London","edition":"3"},{"key":"637_CR5","doi-asserted-by":"publisher","first-page":"117954761875802","DOI":"10.1177\/1179547618758022","volume":"11","author":"A Su\u00e1rez-Lled\u00f3","year":"2018","unstructured":"Su\u00e1rez-Lled\u00f3 A, Padull\u00e9s A, Lozano T et al (2018) Management of tizanidine withdrawal syndrome: a case report. Clin Med Insights Case Rep 11:1179547618758022. \nhttps:\/\/doi.org\/10.1177\/1179547618758022","journal-title":"Clin Med Insights Case Rep"},{"key":"637_CR6","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.3390\/ijms12053250","volume":"12","author":"R Zhu","year":"2011","unstructured":"Zhu R, Hu L, Li H et al (2011) Novel natural inhibitors of CYP1A2 identified by in silico and in vitro screening. Int J Mol Sci 12:3250\u20133262. \nhttps:\/\/doi.org\/10.3390\/ijms12053250","journal-title":"Int J Mol Sci"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-019-00637-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10286-019-00637-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-019-00637-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T01:48:19Z","timestamp":1600307299000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10286-019-00637-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["637"],"URL":"https:\/\/doi.org\/10.1007\/s10286-019-00637-5","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,18]]},"assertion":[{"value":"5 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M.C.F. and I.B. have no conflicts of interest to declare. C.A.S. has received a research grant from the Doris Duke Foundation; grant support from the Office of Orphan Products Development; Food and Drug Administration, Grant #FD-R-04778-01-A3; speaker honorarium from Lundbeck Pharmaceuticals; consulting honoraria from Lundbeck and Theravance Biopharma. C.A.S. is member of the Board for the American Autonomic Society.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This work was approved by the Institutional Review Board and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}